SBIR Phase I: Development of a novel technology to manufacture animal-free muscle proteins in bacteria and yeasts
SBIR 第一阶段:开发一种在细菌和酵母中制造非动物肌肉蛋白的新技术
基本信息
- 批准号:2036161
- 负责人:
- 金额:$ 25.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-15 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The broader impact/commercial impact of this Small Business Innovation Research (SBIR) Phase I project includes improved food security, environmental benefits, and human health benefits. This project will develop a meat alternative that more closely mimics the taste and texture of animal meat. The technology developed from the proposed project will be used to build a vertically integrated food manufacturing platform that can withstand supply chain disruptions from natural disasters and pandemics. These meat alternatives will reduce and replace traditional meat consumption, with many environmental benefits - lowered greenhouse gas emissions and aquatic pollution; lower use of energy, water and land; and reduced antibiotics usage. There are benefits to human health for reduced meat consumption. Furthermore, production costs will be eventually be comparable to that of mushroom farming.The proposed project aims to develop a fermentation-based meat alternative that more closely mimics the taste and texture of animal meal through recombinant protein technologies. Additionally, the project aims to leverage the texture and flavor of mushroom mycelia, and supplement this with recombinant muscle proteins to further enhance the taste and nutritional profiles and overcome many of the shortcomings of existing plant-based meat products. To date the concept of combining recombinant muscle protein and single cell protein is novel and has not been reported. Large gaps persist between plant-based and lab-grown meat, with regards to cost and consumer experience. Plant-based meat is more affordable but faces consumer resistance due to sub-optimal texture and nutritional profiles, while cultivated meat offers a consumer experience similar to that of animal meat but at a much higher cost. Towards this goal, muscle protein genes will be expressed in a microbial host and enzymatically cross-linked with vegetable protein to produce protein fibers that can be formulated into synthetic meat. The technical objectives also include demonstration the feasibility of crosslinking muscle fiber proteins extracted from meat with mycoprotein from mushroom to produce desired textural and flavor properties.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
这一小企业创新研究(SBIR)第一阶段项目的更广泛的影响/商业影响包括改善粮食安全,环境效益和人类健康效益。 该项目将开发一种肉类替代品,更接近模仿动物肉的味道和质地。 从拟议项目开发的技术将用于建立一个垂直整合的食品制造平台,可以抵御自然灾害和流行病造成的供应链中断。这些肉类替代品将减少和取代传统的肉类消费,具有许多环境效益-减少温室气体排放和水污染;减少能源,水和土地的使用;减少抗生素的使用。减少肉类消费对人类健康有好处。此外,生产成本最终将与蘑菇养殖成本相当。拟议项目旨在开发一种基于发酵的肉类替代品,通过重组蛋白技术更接近动物粉的味道和质地。 此外,该项目旨在利用蘑菇菌丝体的质地和风味,并补充重组肌肉蛋白,以进一步增强味道和营养成分,并克服现有植物性肉制品的许多缺点。迄今为止,将重组肌肉蛋白和单细胞蛋白结合的概念是新颖的,尚未报道。在成本和消费者体验方面,植物性肉类和实验室培育肉类之间仍然存在巨大差距。植物肉价格更实惠,但由于质地和营养状况欠佳而面临消费者抵制,而种植肉提供了与动物肉相似的消费体验,但成本要高得多。为了实现这一目标,肌肉蛋白基因将在微生物宿主中表达,并与植物蛋白酶促交联,产生可配制成合成肉的蛋白纤维。该奖项的技术目标还包括展示从肉类中提取的肌纤维蛋白与蘑菇中的真菌蛋白交联的可行性,以产生所需的质构和风味特性。该奖项反映了NSF的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chenfeng Lu其他文献
Chenfeng Lu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark
Supercooled Phase Transition
- 批准号:24ZR1429700
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
ATLAS实验探测器Phase 2升级
- 批准号:11961141014
- 批准年份:2019
- 资助金额:3350 万元
- 项目类别:国际(地区)合作与交流项目
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
- 批准号:41802035
- 批准年份:2018
- 资助金额:12.0 万元
- 项目类别:青年科学基金项目
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究
- 批准号:61675216
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Phase-type分布的多状态系统可靠性模型研究
- 批准号:71501183
- 批准年份:2015
- 资助金额:17.4 万元
- 项目类别:青年科学基金项目
纳米(I-Phase+α-Mg)准共晶的临界半固态形成条件及生长机制
- 批准号:51201142
- 批准年份:2012
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
连续Phase-Type分布数据拟合方法及其应用研究
- 批准号:11101428
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
D-Phase准晶体的电子行为各向异性的研究
- 批准号:19374069
- 批准年份:1993
- 资助金额:6.4 万元
- 项目类别:面上项目
相似海外基金
SBIR Phase I: Development of wearable medical device to detect and treat opioid overdose.
SBIR 第一阶段:开发可穿戴医疗设备来检测和治疗阿片类药物过量。
- 批准号:
2335577 - 财政年份:2024
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
SBIR Phase I: Industrial-Scale Technology for Drug Development in Mature Human Fat Cells
SBIR 第一阶段:成熟人类脂肪细胞药物开发的工业规模技术
- 批准号:
2322443 - 财政年份:2024
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
SBIR Phase II: Development of a Novel Measurement Technology to Enable Longitudinal Multiomic Investigations of the Gut Microbiome
SBIR 第二阶段:开发新型测量技术以实现肠道微生物组的纵向多组学研究
- 批准号:
2314685 - 财政年份:2024
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement
SBIR Phase I: Development of a SERS-based diagnostic platform for multiplexing ubiquitous inflammatory markers in cancer.
SBIR 第一阶段:开发基于 SERS 的诊断平台,用于多重癌症中普遍存在的炎症标记物。
- 批准号:
2348543 - 财政年份:2024
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
SBIR Phase II: Adaptable Ad Hoc Network Architecture for Rapid Infrastructure Development in Disaster Zones
SBIR 第二阶段:用于灾区快速基础设施开发的适应性 Ad Hoc 网络架构
- 批准号:
2322049 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Development of an industrial flow meter for low-volume dispensing
SBIR 第二阶段:开发用于小容量点胶的工业流量计
- 批准号:
2322302 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement
SBIR Phase I: Design and Development of Minimally-Invasive Orthopedic Fracture Fixation Using Intramedullary Sleeve and Injectable, Light-Triggered Bone Cement
SBIR 第一阶段:使用髓内套管和可注射光触发骨水泥的微创骨科骨折固定的设计和开发
- 批准号:
2322411 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
SBIR Phase I: Development of an Adjustable Gene Therapy Platform Technology
SBIR 第一阶段:可调节基因治疗平台技术的开发
- 批准号:
2240683 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
SBIR Phase I: Development of an enzymatic method to produce compounds found in human milk at commercial scale
SBIR 第一阶段:开发酶法以商业规模生产母乳中的化合物
- 批准号:
2304250 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
SBIR Phase I: Development of novel artificial intelligence (AI)-enabled, non-invasive, heart attack diagnostics
SBIR 第一阶段:开发新型人工智能 (AI) 支持的非侵入性心脏病诊断
- 批准号:
2208248 - 财政年份:2023
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant